An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

The department says seniors in congregate living are at highest risk. Starting April 1st, NL Health Services will begin ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...